Call Development of Therapeutics and Diagnostics Combatting Coronavirus Infections

Topic

Development of therapeutics and diagnostics combatting coronavirus infections

Scope: Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:

  • development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
  • development of therapeutics to address the current and/or future coronavirus outbreaks;
  • development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
  • development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.

Preventive vaccines are specifically excluded from the scope of the Call.

For full details of the topic, including the budget breakdown and the General Conditions for the Call for proposals, click on the links above (which take you directly to the relevant page of the Participant Portal) or read the IMI2 - Call 21 Text.

Applicants are also strongly advised to read this questions and answers document.

Indicative budget

From EFPIA companies and IMI2 Associated Partners: to be defined based upon selected proposals.
From the IMI2 JU: EUR 45 000 000.

Key dates and deadlines

Draft topic texts published: 17 February 2020
Publication date: 3 March 2020
Submission start date: 3 March 2020
Submission deadline: 31 March 2020

How to apply

All documents relating to the Call can be found via the Funding and Tenders Portal and the IMI2 Call documents page, in particular the IMI Manual for evaluation, submission and grant award - version 1.7.

Proposals must be submitted via the electronic submission system of the Funding and Tenders Portal. To start submitting your proposal, simply click on the relevant topic above - this will take you directly to that topic's page on the Participant Portal. Once there, scroll down and click on 'Start submission'.

Detailed guidance on how to submit a proposal, including a detailed user manual and frequently asked questions, can be found under the Submit a Proposal section of the Participant Portal Horizon 2020 Online Manual.

To submit a proposal via the electronic submission system, applicants will need to have an EU Login account and ensure that their organisation is registered as a beneficiary.

Useful information

Sign up to / catch up on the IMI2 – Call 21 webinar.

Read our tips for applicants and advice on finding project partners.

Get support

Contact the IMI Programme Office.

Source: IMI

Call Development of Therapeutics and Diagnostics Combatting Coronavirus Infections

‹ News overview